12-68689593-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_020401.4(NUP107):c.161G>A(p.Arg54Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000776 in 1,611,460 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_020401.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NUP107 | NM_020401.4 | c.161G>A | p.Arg54Gln | missense_variant | 3/28 | ENST00000229179.9 | NP_065134.1 | |
NUP107 | NM_001330192.2 | c.46G>A | p.Glu16Lys | missense_variant | 3/28 | NP_001317121.1 | ||
NUP107 | XM_005269037.5 | c.161G>A | p.Arg54Gln | missense_variant | 3/27 | XP_005269094.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000513 AC: 78AN: 151990Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000493 AC: 123AN: 249514Hom.: 0 AF XY: 0.000430 AC XY: 58AN XY: 134954
GnomAD4 exome AF: 0.000803 AC: 1172AN: 1459352Hom.: 0 Cov.: 29 AF XY: 0.000773 AC XY: 561AN XY: 726038
GnomAD4 genome AF: 0.000513 AC: 78AN: 152108Hom.: 0 Cov.: 33 AF XY: 0.000444 AC XY: 33AN XY: 74342
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 17, 2021 | The c.161G>A (p.R54Q) alteration is located in exon 3 (coding exon 3) of the NUP107 gene. This alteration results from a G to A substitution at nucleotide position 161, causing the arginine (R) at amino acid position 54 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 16, 2023 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 54 of the NUP107 protein (p.Arg54Gln). This variant is present in population databases (rs139991199, gnomAD 0.08%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with NUP107-related conditions. ClinVar contains an entry for this variant (Variation ID: 2198280). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at